Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The IRON2 Study. A Retrospective Observational Study to Describe the Evolution of Iron Overload in Patients with Low-Risk Myelodysplastic Syndrome

Angel Remacha, MD, PhD, Beatriz Arrizabalaga, MD, Ana Villegas, Maria Soledad Duran, Lourdes Hermosin, MD, Raquel de Paz, Marta García, Regina García, Consuelo del Cañizo, MD, Silvia Sanz, Guillermo Sanz

Blood (2012) 120 (21): 1723.

https://doi.org/10.1182/blood.V120.21.1723.1723

Published: 2012

Journal Articles

Lenalidomide Differentially Modifies the Genomic Profile and miRNA Expression of Mesenchymal Stromal Cells From Patients with 5q- Syndrome,

Sandra Muntión, PhD, Carlos Santamaría, PhD, Beatriz Roson, Carlos Romo, Olga López-Villar, MD, PhD, Soraya Carrancio, PhD, Fermin M. Sanchez-Guijo, MD, PhD, María Diez-Campelo, MD, PhD, Maria-Eugenia Sarasquete, PhD, Javier de las Rivas, PhD, Marcos González, MD, Jesus F. San Miguel, MD, PhD, Maria-Consuelo del Cañizo, MD, PhD

Blood (2011) 118 (21): 3810.

https://doi.org/10.1182/blood.V118.21.3810.3810

Published: 2011

Journal Articles

Outcomes for Patients (Pts) with Low-/Int-1-Risk Myelodysplastic Syndromes (MDS) with del5q Aged < 65 Years Treated with Lenalidomide (LEN) in MDS-003 and MDS-004: A Retrospective Combined Analysis

Pierre Fenaux, MD, PhD, Aristoteles Giagounidis, MD, Alan F. List, MD, Stephen D. Nimer, MD, Eva Hellström-Lindberg, Bayard L. Powell, MD, Xujie Yu, PhD, Barry Skikne, MD, Jamile M. Shammo, MD, Consuelo del Cañizo, MD

Blood (2011) 118 (21): 1723.

https://doi.org/10.1182/blood.V118.21.1723.1723

Published: 2011

Journal Articles

A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.

Blood (2009) 114 (22): 1750.

https://doi.org/10.1182/blood.V114.22.1750.1750

Published: 2009

Journal Articles

RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low- or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004).

Pierre Fenaux, Aristotle Giagounidis, Dominik Selleslag, MD, Odile Beyne-Rauzy, MD, PhD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Moshe Mittelman, MD, Petra Muus, MD, PhD, Peter te Boekhorst, MD, PhD, Guillermo Sanz, MD, PhD, Consuelo del Cañizo, Agnes Guerci-Bresler, Brigitte Schlegelberger, M.D., Carlo Aul, Hans Kreipe, MD, Gudrun Goehring, Robert Knight, MD, John Francis, Tommy Fu, Eva Hellstrom-Lindberg, MD, PhD

Blood (2009) 114 (22): 944.

https://doi.org/10.1182/blood.V114.22.944.944

Published: 2009

Journal Articles

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Blood (2009) 114 (22): 290.

https://doi.org/10.1182/blood.V114.22.290.290

Published: 2009

Journal Articles

Both Expanded and Uncultured Mesenchymal Stem Cells from MDS Patients Are Genomically Abnormal, Showing a Specific Genetic Profile for the 5q- Syndrome.

Olga López Villar, MD, Juan LuíS. García, PhD, Fermín. M Sánchez Guijo, MD, PhD, Cristina Robledo, Pilar Hernandez Campo, PhD, Maria Diez Campelo, MD, PhD, Sandra Muntion, Jose Antonio Pérez Simón, MD, PhD, J.F. San Miguel, MD, PhD, MaríA. Consuelo Del Cañizo, MD, PhD

Blood (2008) 112 (11): 1650.

https://doi.org/10.1182/blood.V112.11.1650.1650

Published: 2008

Journal Articles

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

Blood (2008) 112 (11): 640.

https://doi.org/10.1182/blood.V112.11.640.640

Published: 2008

Journal Articles

Mesenchymal Stem Cells from Patients with Myelodysplastic Syndromes Are Functionally and Genomically Abnormal.

Olga López Villar, MD, Fermin M. Sánchez-Guijo, PhD, Juan Luis García, PhD, Jose Ramon González Porras, PhD, Eva Villarón, PhD, Natalia López-Holgado, PhD, Jose Antonio Pérez Simón, PhD, J.F. San Miguel, PhD, María Consuelo Del Cañizo, PhD

Blood (2007) 110 (11): 1916.

https://doi.org/10.1182/blood.V110.11.1916.1916

Published: 2007

Journal Articles

Comparison between Progenitor Cells from Mobilized Peripheral Blood (PB) in Healthy Donors and Non-Hodgkin’s Lymphoma (NHL) Patients.

Eva M. Villaron, PhD, Julia Almeida, PhD, MD, Natalia Lopez-Holgado, PhD, Fermin M. Sanchez-Guijo, PhD, MD, Mercedes Alberca, PhD, Belen Blanco, PhD, Luis I. Sanchez-Abarca, PhD, Olga Lopez, MD, Jose A. Perez-Simon, PhD, MD, Jesus F. San Miguel, PhD, MD, Consuelo del Cañizo, PhD, MD

Blood (2004) 104 (11): 5002.

https://doi.org/10.1182/blood.V104.11.5002.5002

Published: 2004

Journal Articles

Minimal Residual Disease (MRD) Evaluation by Flow Cytometry in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Maria-Belen Vidriales, MD, PhD, Jose J. Pérez, Consuelo López-Berges, MD, PhD, Norma C. Gutierrez, MD, PhD, Juana Ciudad, PhD, Lourdes Vazquez, MD, PhD, Consuelo del Cañizo, MD, PhD, Joaquín Díaz-Mediavilla, MD, PhD, Javier Fernández-Calvo, MD, Fernando Ramos, MD, PhD, María Jesús Rodriguez, MD, PhD, María José Calmuntia, MD, PhD, Alberto Orfao, MD, PhD, Jesús San Miguel, MD, PhD

Blood (2004) 104 (11): 1103.

https://doi.org/10.1182/blood.V104.11.1103.1103

Published: 2004

Journal Articles

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value

María-Belén Vidriales, José J. Pérez, Maria Consuelo López-Berges, Norma Gutiérrez, Juana Ciudad, Paulo Lucio, Lourdes Vazquez, Ramón García-Sanz, Maria Consuelo del Cañizo, Javier Fernández-Calvo, Fernando Ramos, M. Jesús Rodríguez, M. José Calmuntia, Ana Porwith, Alberto Orfao, Jesús F. San-Miguel

Blood (2003) 101 (12): 4695–4700.

https://doi.org/10.1182/blood-2002-08-2613

Published: 2003

NARROW

The IRON2 Study. A Retrospective Observational Study to Describe the Evolution of Iron Overload in Patients with Low-Risk Myelodysplastic Syndrome

Lenalidomide Differentially Modifies the Genomic Profile and miRNA Expression of Mesenchymal Stromal Cells From Patients with 5q- Syndrome,

Outcomes for Patients (Pts) with Low-/Int-1-Risk Myelodysplastic Syndromes (MDS) with del5q Aged < 65 Years Treated with Lenalidomide (LEN) in MDS-003 and MDS-004: A Retrospective Combined Analysis

A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.

RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low- or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004).

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Both Expanded and Uncultured Mesenchymal Stem Cells from MDS Patients Are Genomically Abnormal, Showing a Specific Genetic Profile for the 5q- Syndrome.

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

Mesenchymal Stem Cells from Patients with Myelodysplastic Syndromes Are Functionally and Genomically Abnormal.

Comparison between Progenitor Cells from Mobilized Peripheral Blood (PB) in Healthy Donors and Non-Hodgkin’s Lymphoma (NHL) Patients.

Minimal Residual Disease (MRD) Evaluation by Flow Cytometry in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only